CIK 0001705843
- Non-accelerated filer
- Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271967997
- Phone
- +1 858-450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-18 | Kozicz-Stankiewicz Anna Ewa Director | Sale | −735 | $10.00 | $7K | 4,145 |
| 2019-07-18 | Dumont Philippe Director | Sale | −706 | $10.00 | $7K | 2,234 |
| 2019-07-01 | Sahoo Manoj Chief Commercial Officer | Sale | −1,494 | $12.70 | $19K | 65,323 |
| 2019-06-28 | Voytas Daniel F Chief Science Officer | Grant or award | +50,000 | 142,982 | ||
| 2019-06-28 | Frimerman Debra H General Counsel | Grant or award · Performance Stock Units | +60,000 | 60,000 | ||
| 2019-06-28 | Koschak William Chief Financial Officer | Grant or award · Performance Stock Units | +85,000 | 85,000 | ||
| 2019-06-28 | Blome James Chief Executive Officer | Grant or award | +50,000 | 204,136 | ||
| 2019-06-28 | Blome James Chief Executive Officer | Grant or award · Stock Option (Right-to-Buy) | +125,000 | 125,000 | ||
| 2019-06-28 | Blome James Chief Executive Officer | Grant or award · Performance Stock Units | +166,667 | 166,667 | ||
| 2019-06-14 | Choulika Andre Director | Shares withheld for taxes | −15,715 | $12.90 | $203K | 138,733 |
| 2019-05-20 | Frey Travis Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-05-15 | Choulika Andre Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2019-05-13 | Frimerman Debra H General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-05-13 | Voytas Daniel F Chief Science Officer | Grant or award · Stock Option (Right to Buy) | +68,000 | 68,000 | ||
| 2019-05-13 | Sahoo Manoj Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +68,000 | 68,000 | ||
| 2019-05-06 | Choulika Andre Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-05-06 | Dumont Philippe Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-05-06 | Ribeill Yves J Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-05-06 | Jonathan Fassberg Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-05-06 | NEUGENT CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 |
Page 22 of 27 · 525 trades